Gain Therapeutics Inc (GANX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.48
• Market Cap: $96.92M
• EPS: $-0.61
• 52-Week High: $4.34
• 52-Week Low: $1.41

Market Sentiment

Gain Therapeutics Inc currently has a Bullish sentiment score of 0.24.

About Gain Therapeutics Inc

Gain Therapeutics Inc. is a biotechnology firm headquartered in Bethesda, Maryland, dedicated to developing innovative therapies aimed at combating diseases related to protein misfolding. Utilizing its proprietary drug discovery platform, the company is advancing a robust pipeline of candidate therapies targeting neurodegenerative and other serious disorders. With a strong emphasis on addressing significant unmet medical needs, Gain Therapeutics is strategically positioned to make impactful c...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Gain Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GANX pay dividends?

Gain Therapeutics Inc (GANX) does not currently pay a regular dividend.

What is GANX's market cap?

Gain Therapeutics Inc (GANX) has a market capitalization of $96.92M with a current stock price of $2.48.